Āyuṛveda management of keratosis pilaris – a case report

2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Rajasadanam Samsakumar Vipinsha ◽  
Changuli Krishna Bhat Prathibha ◽  
Puthanmadom Venkatraramana Sharma Anandaraman
Keyword(s):  
Case Report ◽  
Side Effects ◽  
Symptomatic Relief ◽  
Complete Recovery ◽  
Upper Arm ◽  
Case Presentation ◽  
The Past ◽  
Short Period ◽  
Two Phases ◽  
Universal Treatment

AbstractObjectivesKeratosis pilaris (KP) is the condition of the skin with extensive keratin follicular plugging. It may be associated with the erythema. The upper arm extensor area, shoulders, back of neck and thighs, as well as face and the upper trunk are the areas of presentation. Available medications for KP give only symptomatic relief, while some produce serious side effects. There is no proven universal treatment for the disease that can provide complete recovery. Āyuṛveda management of KP is not yet reported.Case presentationA 26-year-old male patient, presented with main complaints started with papular lesions over his right shoulder, chest and upper back along and later with pustular lesions in the past 2 weeks. The condition was associated with redness, mild swelling and itching. The case was diagnosed as Keratosis pilaris based on its presentation, site, and pathogenesis. Also by analyzing the extent of vitiation of doṣas (morbidities), the Vata kapha pitta hara line of treatment was adopted, which was accomplished in two phases i. e. Śodhana Cikitsa and Śamana Cikitsa.ConclusionBoth internal and external treatments along with diet restrictions were found effective in arresting the pathogenesis and recovery in a short period. All the symptoms associated with the condition were completely cured with no signs of re-occurrence.

Management of Vipadika with Mahisha Gritha Padanimajjana – a case report

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Sharanya Suseela ◽  
Anandaraman Puthanmadom Venkatraramana Sharma ◽  
Kesavan Parameswaran Namboothiri ◽  
Prathibha Changuli Krishna Bhat
Keyword(s):  
Case Report ◽  
Side Effects ◽  
Effective Treatment ◽  
Skin Disorder ◽  
Severe Pain ◽  
Case Presentation ◽  
Treatment Methods ◽  
Treatment Line ◽  
Short Period ◽  
Ayurvedic Treatment

Abstract Objectives Vipadika (Palmo plantar Psoriasis) is a Kshudra Kushta (minor skin disorder) of Vatakapha origin (body humors like vata and kapha) characterized by Sphutana (cracks) and Teevra Vedana (severe pain) in Pani (palm) and Pada (sole). Based on the symptoms it can be correlated to Palmo Plantar Psoriasis which is a variant of psoriasis which affects the skin of the palms and soles with the features of hyperkeratotic, pustular, or mixed morphologies. The treatment methods for Palmo plantor psoriasis causes severe side effects due to which an evident shift from modern treatments to ayurvedic treatment line. Case presentation A 15 year old, female, with complaint of cracks and dryness over sole of both feet with pain for the last 12 and half years. The case was managed with Padanimajjana (immersion of foot). Padanimajjana is a modified form of Avagaha Sweda (switz bath) where the affected part of the foot is dipped in medicated liquid. Here Mahisha Gritha (Buffaloe ghee) is used for Padanimajjana. Conclusions Mahisha Gritha Padanimajjana shows significant improvement in number of cracks, dryness and pain within short period of time. This is a very simple, economical, and effective treatment for Vipadika.

scholarly journals Case Report: Migrainous Infarct without Aura

2017 ◽  
Vol 9 (3) ◽  
pp. 241-251
Author(s):  
Kamesh Gupta ◽  
Anurag  Rohatgi ◽  
Shivani Handa
Keyword(s):  
Risk Factors ◽  
Ischemic Stroke ◽  
Case Report ◽  
Rare Case ◽  
Case Presentation ◽  
The Past ◽  
Need To Evaluate ◽  
History Of ◽  
Complicated Migraine ◽  
Full Investigation

Background: Stroke in a migraine with aura has been documented in several cases, even deserving the merit of a classification as complicated migraine. Herein, we present a rare case of migrainous infarct without aura. The diagnosis was challenging due to lack of risk factors. The patient was unique in not having any other comorbidities. Case Presentation: The case is of a 21-year-old female presenting with right-sided hemiplegia and facial drooping. She had had an index presentation of throbbing headaches for the past 2 years, typical of a migraine but not preceded by any aura symptoms. However, in the current episode, the pain became excessively severe and accompanied by right-sided hemiplegia and facial drooping. A full investigation workup using MRI revealed evidence of infarct in the left temporoparietal and basal ganglion region. Conclusion: Our case highlights the need to evaluate silent ischemic stroke in case of prolonged headache with a history of migraine as well as the need for precaution to avoid the use of triptans or opioids in such a case. It also highlights the conditions that need to be excluded before labeling it as a migrainous infarct.

scholarly journals New Onset Focal Seizure Following COVID-19 Vaccination: Case Report

2021 ◽  
Author(s):  
Chun Seng Phua ◽  
Shalini Bhaskar ◽  
Azman Ali Raymond
Keyword(s):  
Case Report ◽  
Side Effects ◽  
Focal Seizure ◽  
Seizure Threshold ◽  
Hippocampal Atrophy ◽  
Case Presentation ◽  
Mri Brain ◽  
Focal Seizures ◽  
Patient’S History ◽  
New Onset

Abstract IntroductionAs more novel COVID-19 vaccines are being rolled out in a frantic pace globally, any complication that might be related to COVID-19 vaccines should be highlighted, especially since COVID-19 vaccines are relatively new, and side effects may yet to be fully elucidated. We report a case of a healthy 18-year-old male who presented with new onset focal seizures 5 days after receiving 1st dose of Oxford/AstraZeneca COVID-19 vaccine. Case PresentationThe patient was treated with intravenous phenytoin and oral levetiracetam 250mg twice daily with no further events. There was no documented fever. CT venogram and EEG were unremarkable. MRI brain revealed generalised atrophy including mild bilateral hippocampal atrophy with no evidence of sclerosis. There was no predilection for seizures identified from the patient’s history. The patient was discharged the following day on levetiracetam and advised to proceed with the 2nd dose of Oxford/AstraZeneca COVID-19 vaccination in 3 months’ time.ConclusionSeizures following COVID-19 vaccination have only been reported in a handful of cases. COVID-19 vaccination could lower seizure threshold, or unmask an underlying predisposition for epilepsy. As most COVID-19 vaccines worldwide are given in 2 doses, clinicians should consider maintaining patients on anti-seizure drugs if vaccination was thought to be a provoking factor.

Colchicine may Induce Isolated and Reversible Oculomotor Neuropathy

2021 ◽  
Vol 16 ◽  
Author(s):  
Gaetano Gorgone ◽  
Massimiliano Plastino ◽  
Antonio Vaccaro ◽  
Antonietta Fava ◽  
Domenico Bosco
Keyword(s):  
Side Effects ◽  
Neurological Examination ◽  
Complete Recovery ◽  
Cranial Neuropathy ◽  
Cranial Nerve Deficit ◽  
Case Presentation ◽  
Clinical Investigations ◽  
Iatrogenic Origin ◽  
Colchicine Therapy

Background: Colchicine is a medication described by a complex constellation of side effects. Case presentation: We report the case of an 80s- 80-year-old subject, treated with colchicine, who developed a left monolateral ptosis with horizontal diplopia after treatment with oral colchicine. Two months later, he underwent a clinical follow-up and complete recovery of the previous third cranial nerve deficit was reported at neurological examination. A few months later, colchicine therapy was reported with a reappearance of the same ocular deficit. Conclusion: Our report suggests that patients receiving colchicine should be followed prudently and, a possible iatrogenic origin of an isolated ocular cranial neuropathy must be taken into account, especially when other potential etiological entities are excluded by the instrumental and laboratory clinical investigations.

scholarly journals COVID-19 causing acute deterioration of interstitial lung disease: a case report

2021 ◽  
Vol 52 (1) ◽  
Author(s):  
Mohamed Rafi Kathar Hussain ◽  
N. Kulasekaran ◽  
A. M. Anand ◽  
Padma Reka Danassegarane
Keyword(s):  
Case Report ◽  
Interstitial Lung Disease ◽  
Lung Disease ◽  
Heterogeneous Group ◽  
Organ Involvement ◽  
Lung Involvement ◽  
Case Presentation ◽  
The Past ◽  
Diffuse Lung

Abstract Background Interstitial lung disease (ILD) comprises a heterogeneous group of disorders characterized by multifocal diffuse lung involvement. Similarly, COVID-19 has varied multispectral organ involvement. Patients with underlying ILD and coexistent COVID-19 infection may lead to an acute blow to the already deceased lung. Case presentation A 58-year-old man presented with fever and cough with expectoration for the past 4 days associated with breathlessness. He was a smoker and alcoholic for the past 20 years. His saturation was low in room air around 84% and improved to 98% with 10 l/min of nasal oxygen. Further investigation shows acute deterioration of ILD. Conclusion COVID-19 infection has a spectrum of manifestations. Acute deterioration of ILD is rarely reported in the literature. Etiology should be investigated further.

scholarly journals Menorrhagia in Women After the Administration of Novel Oral ‎Anticoagulants, Like Rivaroxaban: A Case Report

2020 ◽  
Vol 10 (3) ◽  
pp. 29640
Author(s):  
Jalil ‎ Feizi ◽  
Ali Nazari ◽  
Abbas ‎ Ghaysouri ◽  
Mahtab Bonyadi ◽  
Elham Shafiei
Keyword(s):  
Adverse Effect ◽  
Case Report ◽  
Side Effects ◽  
Vaginal Bleeding ◽  
Oral Anticoagulants ◽  
Ease Of Use ◽  
Novel Oral Anticoagulants ◽  
The Novel ◽  
Case Presentation ◽  
Drug Involvement

Background: The Novel Oral Anticoagulants (NOACs), despite numerous benefits, such as the ease of use and less drug involvement, provide extensive adverse effects. One of the most significant, but rare side effects of them in women is severe and dangerous bleeding. Case presentation: In this study, we reported a case of severe vaginal bleeding (manometric hemorrhage) in a woman receiving rivaroxaban to prevent pulmonary thrombosis. Conclusion: The oral anticoagulant rivaroxaban could present a rare adverse effect on women.  

scholarly journals Nasopharyngeal Metastasis From Colorectal Cancer: A Case Report

2020 ◽  
Author(s):  
Ye-Huan Liu ◽  
Bei-Bei Lin ◽  
Shi-Xu Lv
Keyword(s):  
Colorectal Cancer ◽  
Rectal Cancer ◽  
Case Report ◽  
Radical Surgery ◽  
Distant Metastases ◽  
Clinical Aspects ◽  
Case Presentation ◽  
The Past

Abstract Background: Nasopharyngeal metastasis from colorectal cancer has never been reported in the past. Case presentation: In this paper, we establish a case report of a 79-year-old man suffering from adenocarcinoma of the rectum with distant metastases to the liver, lung, and nasopharynx. Over the past 7 years, he received radical surgery for rectal cancer (miles surgery), chemotherapy, hepatectomy, and pneumonectomy. Conclusions: We equally discuss the histopathological and clinical aspects associated with this condition.

EVALUATION OF SIDE EFFECTS OF INFLUENZA VACCINE ON THE ORAL HEALTH AND CORRELATION WITH FLU

2021 ◽  
Vol 5 (3) ◽  
Author(s):  
Pragya Jaiswal ◽  
Raghav Agrawal
Keyword(s):  
Side Effects ◽  
Oral Cavity ◽  
Influenza Vaccine ◽  
Large Population ◽  
Pain Scale ◽  
Common Symptom ◽  
Upper Arm ◽  
The Past ◽  
Oral Symptoms ◽  
Flu Vaccine

Background: Vaccines have come a long way. They have been an important aspect of controlling and eradicating various life-threatening diseases. Vaccination is being widely used for Influenza which is one of the most common conditions affecting a large population and affects day to day activity. A vaccine being a double-edged sword, it presents various side effects as a whole and on oral cavity like ulcers, bleeding gums, white spots, sores in the oral cavity, lips, along with halitosis, etc. Objective: This prospective study was aimed to assess and understand the bad impact on by influenza vaccine on the oral cavity as well as to establish if any correlation exists between the flu vaccine and adverse oral symptoms. Methods: A total of 268 subjects studying at Government Medical College, were randomly screened for the study. Out of which only 32 received the vaccine for influenza in the past 6 months. All the subjects were given a multiple-choice questionnaire consisting of 12 short response questions related to general and oral side effects post-vaccination. The data collected was evaluated and assessed. Results: Study subjects that took the influenza vaccine within a period of the past 6 months, only ten patients suffered by side effects in which 6 suffered from flu-like symptoms and only 4 suffered orally-related symptoms simultaneously. Three manifestations that were found related to the oral cavity were white patches in the oral cavity, swelling of the lips, and atypical oral ulcers, soreness, swelling, redness, and pain in the upper arm. Other symptoms encountered in responders were fever, weakness, headache, and dizziness. The results of the present study indicated that 30% (n=3) of participants reported moderate pain (level 2). The remaining 70% reported levels 1, 3, and 5 pain with 30% reported level 1, 20% level 3 pain, and 20% level 5 pain respectively of Likert’s Pain Scale. Only 2 subjects (20%) required medical treatment for experienced symptoms. The severely unbearable pain of level 5 was reported by 2 subjects. Conclusions: No substantial relationship is observed between receiving the flu vaccine and oral symptoms. The most common symptom reported by survey participants were soreness, redness, and swelling in the upper arm with associated pain. All these systems are part of body immune defence to foreign vaccine particles and are cured naturally with immunity. Keywords:  Flu, Immune Reaction, Influenza, Oral Cavity, Vaccination.

scholarly journals FEBRILE INFECTION-RELATED EPILEPSY SYNDROME: A RARE CASE PRESENTATION

2017 ◽  
Vol 10 (3) ◽  
pp. 6
Author(s):  
Remya Reghu ◽  
Aloysius James ◽  
Reshma Reji ◽  
Bini Vincent ◽  
Nimmu Mani
Keyword(s):  
Case Report ◽  
Status Epilepticus ◽  
Side Effects ◽  
Rare Case ◽  
Treatment Options ◽  
Treatment Strategies ◽  
Refractory Status Epilepticus ◽  
Epilepsy Syndrome ◽  
Case Presentation ◽  
Refractory Status

ABSTRACTFebrile infection-related epilepsy syndrome is characterized by super refractory status epilepticus that is resistant to conventional antiepileptic drugs.This case report critically analyses the treatment options adopted in a hospital to manage this syndrome. Despite the aggressive efforts that weretaken, the patient succumbed to the complications of the illness and side effects of the treatment strategies adopted. This shows that the treatmentoptions currently available are in adequate, so an intensive research in the area of pathogenesis of status epilepticus is required to frame treatmentstrategies that can bring out better outcomes.Keywords: Antiepileptics, Febrile infection-related epilepsy syndrome, Status epilepticus.

scholarly journals Judicious use of low-dosage corticosteroids for non-severe COVID-19: A case report

Open Medicine ◽  
2021 ◽  
Vol 16 (1) ◽  
pp. 440-445
Author(s):  
Jian Zhang ◽  
Zigang Tian ◽  
Lina Feng ◽  
Zhongming Yang ◽  
Bo Zou ◽  
...  
Keyword(s):  
Case Report ◽  
Lung Injury ◽  
Corticosteroid Therapy ◽  
Complete Recovery ◽  
Evidence Base ◽  
Retrospective Case ◽  
Short Period ◽  
Lung Condition ◽  
Low Dosage ◽  
Systemic Corticosteroid Therapy

Abstract Inflammation-mediated lung injury in severe cases of infection with SARS-CoV-2, the aetiological agent of Coronavirus disease 2019 (COVID-19), can lead to respiratory failure and death, and therapies that block or ameliorate lung injury-associated inflammatory “cytokine storms” and progression to acute respiratory distress syndrome (ARDS) are urgently needed. Therapeutic use of corticosteroids for this purpose has been controversial because of conflicting reports on their efficacy and immunosuppressive behaviour. The WHO has strongly recommended treating critical COVID-19 patients with systemic corticosteroid therapy, but recommends against corticosteroid therapy in non-severe COVID-19 disease because of a lack of strong evidence on its efficacy. This retrospective case report describing the successful treatment of a non-severe COVID-19 case in Changchun, China, by judicious administration of corticosteroids using a personalized therapeutic approach was recorded to strengthen the evidence base showing how corticosteroid use in non-severe COVID-19 cases can be safe and efficacious. Alongside supportive care and lopinavir/ritonavir antiviral drugs, a low dosage of methylprednisolone was administered over a short period to attenuate lung inflammation. Regular chest CT scans guided dosage reduction in response to lesion absorption and improved lung condition. Judicious use of corticosteroids safely attenuated disease progression and facilitated rapid and complete recovery.

Sign in / Sign up

Export Citation Format

Share Document